Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
A Phase 1 Study of Venetoclax (ABT-199 / GDC-0199) Monotherapy in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
Blood (2015)
  • John F. Gerecitano, Memorial Sloan Kettering Cancer Center
  • Andrew W. Roberts, Royal Melbourne Hospital
  • John F. Seymour, Peter MacCallum Cancer Centre
  • William G. Wierda, University of Texas MD Anderson Cancer Center
  • Brad S. Kahl, University of Wisconsin-Madison
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Soham Puvvada, University of Arizona
  • Thomas J. Kipps, University of California, San Diego
  • Mary Ann Anderson, Royal Melbourne Hospital
  • Martin Dunbar
  • Ming Zhu
  • Lori Gressick
  • Lindsay Wagner
  • Su Young Kim
  • Sari Heitner Enschende
  • Rod A. Humerickhouse, Roswell Park Cancer Institute
  • Matthew S. Davids, Harvard University
Link
Disciplines
Publication Date
December 3, 2015
Citation Information
John F. Gerecitano, Andrew W. Roberts, John F. Seymour, William G. Wierda, et al.. "A Phase 1 Study of Venetoclax (ABT-199 / GDC-0199) Monotherapy in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma" Blood Vol. 126 Iss. 23 (2015) p. 254 - 254
Available at: http://works.bepress.com/john-pagel/61/